enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. US FDA approves Roche's drug for a chronic blood disorder ...

   www.aol.com/news/us-fda-approves-roches-drug...

   The approval is based on a late-stage study in which PiaSky showed a 79.3% control in the destruction of red blood cells versus 79% for the standard-of-care eculizumab from week 5 to week 25.

3. US FDA approves Amgen drug for small cell lung cancer - AOL

   www.aol.com/news/us-fda-approves-amgen-drug...

   The U.S. Food and Drug Administration on Thursday granted accelerated approval to Amgen's tarlatamab, a targeted immunotherapy for adults in the advanced stages of hard-to-treat small cell lung ...

4. US FDA approves Zevra's treatment for rare genetic disease - AOL

   www.aol.com/news/us-fda-approves-zevras...

   The oral drug, branded as Miplyffa, has now been approved for the treatment of Neimann-Pick disease type C - a rare genet US FDA approves Zevra's treatment for rare genetic disease Skip to main ...

5. List of American television programs currently in production

   en.wikipedia.org/wiki/List_of_American...

   America's Game: The Super Bowl Champions; America's Got Talent; CNN Newsroom; College Football on NBC Sports; Diners, Drive-Ins and Dives; Fast Money; Football Night in America

6. Fast track (FDA) - Wikipedia

   en.wikipedia.org/wiki/Fast_track_(FDA)

   Once a drug receives fast track designation, early and frequent communication between the FDA and a drug company is encouraged throughout the entire drug development and review process. The frequency of communication assures that questions and issues are resolved quickly, often leading to earlier drug approval and access by patients.

7. Accelerated approval (FDA) - Wikipedia

   en.wikipedia.org/wiki/Accelerated_approval_(FDA)

   Drugs approved under the FDA Accelerated Approval Program still need to be tested in clinical trials using endpoints that demonstrate clinical benefit, and those trials are known as phase 4 confirmatory trials. If the drug later proves unable to demonstrate clinical benefit to patients, the FDA may withdraw approval.

8. US FDA approves Merck's pneumococcal vaccine for adults - AOL

   www.aol.com/news/us-fda-approves-mercks...

   Capvaxive is approved for adults 18 years of age and older, according to the FDA's letter. Pneumococcal disease spreads through direct contact with respiratory secretions such as saliva or mucus.

9. Investigational New Drug - Wikipedia

   en.wikipedia.org/wiki/Investigational_new_drug

   The United States Food and Drug Administration's Investigational New Drug (IND) program is the means by which a pharmaceutical company obtains permission to start human clinical trials and to ship an experimental drug across state lines (usually to clinical investigators) before a marketing application for the drug has been approved.